SCHEMBL8282433

SCHEMBL8282433

Cc1nc(-c2ccc(F)c(N)c2)no1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.57
▸ CA12 O43570 2/20 0.49
▸ CA1 P00915 2/20 0.49
▸ CA2 P00918 2/20 0.49
▸ CA9 Q16790 2/20 0.49
▸ LMNA P02545 2/20 0.46
▸ MAPT P10636 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ ESR2 Q92731 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ PLK1 P53350 1/20 0.44
▸ RAB9A P51151 4/20 0.42
▸ NPC1 O15118 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ MAOA P21397 1/20 0.42
▸ MAOB P27338 1/20 0.42
▸ AOC3 Q16853 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8282389 0.87 L3MBTL1 (0.57) L3MBTL1CA12CA1CA2CA9
SCHEMBL14363620 0.85 L3MBTL1 (0.62) L3MBTL1CA12CA1CA2CA9
SCHEMBL15157090 0.85 L3MBTL1 (0.62) L3MBTL1CA12CA1CA2CA9
SCHEMBL3250198 0.83 L3MBTL1 (0.61) L3MBTL1CA12CA1CA2CA9
SCHEMBL31013417 0.83 L3MBTL1 (0.61) L3MBTL1CA12CA1CA2CA9
SCHEMBL8418331 0.83 L3MBTL1 (0.61) L3MBTL1CA12CA1CA2CA9
SCHEMBL14561488 0.81 L3MBTL1 (0.57) L3MBTL1CA12CA1CA2CA9
SCHEMBL12021892 0.81 L3MBTL1 (0.57) L3MBTL1CA12CA1CA2CA9
SCHEMBL8226165 0.81 L3MBTL1 (0.57) L3MBTL1CA12CA1CA2CA9
SCHEMBL14363616 0.81 L3MBTL1 (0.57) L3MBTL1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745047-B1 PYRAZOLO[4,3-E]-1,2,4-TRIAZOLO[1,5-C]PYRIMIDINE ADENOSINE-A2A- RECEPTOR ANTAGONISTS SCHERING CORP (US) 2010-03-24 — — EP disclosed
WO-2005103055-A1 PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PYRIMIDINE ADENOSINE A2A RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2005-11-03 — — WO disclosed
Send feedback